Anti‐PD1 or anti‐PD‐L1 antibodies alone or in combination with chemotherapy first‐line treatment of advanced non‐small cell lung cancer

• Xuexia Zhang,
• Xiaoping Cai,
• Hao Zheng

Affiliations

Xuexia Zhang

Department Internal Medicine Sixth affiliated Hospital of Wenzhou Medical University, Lishui People's Hospital Lishui PR China

Xiaoping Cai

Department of Respiratory and Intensive Care Unit Sixth affiliated Hospital of Wenzhou Medical University, Lishui People's Hospital Lishui PR China

Hao Zheng

Department of Respiratory and Intensive Care Unit Sixth affiliated Hospital of Wenzhou Medical University, Lishui People's Hospital Lishui PR China